nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—rheumatoid arthritis	0.42	0.788	CbGaD
Gliclazide—ALB—rheumatoid arthritis	0.113	0.212	CbGaD
Gliclazide—ALB—Auranofin—rheumatoid arthritis	0.0934	0.381	CbGbCtD
Gliclazide—CYP2C9—Leflunomide—rheumatoid arthritis	0.0324	0.132	CbGbCtD
Gliclazide—ALB—Prednisone—rheumatoid arthritis	0.0297	0.121	CbGbCtD
Gliclazide—CYP2C19—Prednisone—rheumatoid arthritis	0.0193	0.0786	CbGbCtD
Gliclazide—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0183	0.0745	CbGbCtD
Gliclazide—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0152	0.0619	CbGbCtD
Gliclazide—ALB—Methotrexate—rheumatoid arthritis	0.0149	0.0608	CbGbCtD
Gliclazide—CYP2C19—Dexamethasone—rheumatoid arthritis	0.012	0.0491	CbGbCtD
Gliclazide—CYP2C9—Dexamethasone—rheumatoid arthritis	0.01	0.0408	CbGbCtD
Gliclazide—VEGFA—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.00026	0.0912	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.00026	0.0912	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000246	0.086	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000246	0.086	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000242	0.0847	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000242	0.0847	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000236	0.0827	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000236	0.0827	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisone—rheumatoid arthritis	0.000224	0.0785	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisone—rheumatoid arthritis	0.000224	0.0785	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisolone—rheumatoid arthritis	0.000219	0.0766	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000219	0.0766	CbGdCrCtD
Gliclazide—Mental disorder—Prednisone—rheumatoid arthritis	7.47e-05	0.000497	CcSEcCtD
Gliclazide—Nausea—Azathioprine—rheumatoid arthritis	7.47e-05	0.000497	CcSEcCtD
Gliclazide—Tachycardia—Methylprednisolone—rheumatoid arthritis	7.47e-05	0.000497	CcSEcCtD
Gliclazide—Headache—Leflunomide—rheumatoid arthritis	7.44e-05	0.000495	CcSEcCtD
Gliclazide—Skin disorder—Methylprednisolone—rheumatoid arthritis	7.43e-05	0.000495	CcSEcCtD
Gliclazide—Erythema—Prednisone—rheumatoid arthritis	7.43e-05	0.000494	CcSEcCtD
Gliclazide—Malnutrition—Prednisone—rheumatoid arthritis	7.43e-05	0.000494	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	7.42e-05	0.000494	CcSEcCtD
Gliclazide—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	7.41e-05	0.000493	CcSEcCtD
Gliclazide—Agranulocytosis—Methotrexate—rheumatoid arthritis	7.41e-05	0.000493	CcSEcCtD
Gliclazide—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	7.4e-05	0.000492	CcSEcCtD
Gliclazide—Convulsion—Dexamethasone—rheumatoid arthritis	7.39e-05	0.000492	CcSEcCtD
Gliclazide—Convulsion—Betamethasone—rheumatoid arthritis	7.39e-05	0.000492	CcSEcCtD
Gliclazide—Insomnia—Hydrocortisone—rheumatoid arthritis	7.37e-05	0.00049	CcSEcCtD
Gliclazide—Hypertension—Betamethasone—rheumatoid arthritis	7.36e-05	0.00049	CcSEcCtD
Gliclazide—Hypertension—Dexamethasone—rheumatoid arthritis	7.36e-05	0.00049	CcSEcCtD
Gliclazide—Paraesthesia—Hydrocortisone—rheumatoid arthritis	7.31e-05	0.000487	CcSEcCtD
Gliclazide—Urticaria—Cyclosporine—rheumatoid arthritis	7.28e-05	0.000484	CcSEcCtD
Gliclazide—Myalgia—Betamethasone—rheumatoid arthritis	7.26e-05	0.000483	CcSEcCtD
Gliclazide—Myalgia—Dexamethasone—rheumatoid arthritis	7.26e-05	0.000483	CcSEcCtD
Gliclazide—Abdominal pain—Cyclosporine—rheumatoid arthritis	7.25e-05	0.000482	CcSEcCtD
Gliclazide—Body temperature increased—Cyclosporine—rheumatoid arthritis	7.25e-05	0.000482	CcSEcCtD
Gliclazide—Anxiety—Dexamethasone—rheumatoid arthritis	7.23e-05	0.000481	CcSEcCtD
Gliclazide—Anxiety—Betamethasone—rheumatoid arthritis	7.23e-05	0.000481	CcSEcCtD
Gliclazide—Discomfort—Dexamethasone—rheumatoid arthritis	7.17e-05	0.000477	CcSEcCtD
Gliclazide—Discomfort—Betamethasone—rheumatoid arthritis	7.17e-05	0.000477	CcSEcCtD
Gliclazide—Dyspepsia—Hydrocortisone—rheumatoid arthritis	7.17e-05	0.000477	CcSEcCtD
Gliclazide—Hypotension—Methylprednisolone—rheumatoid arthritis	7.15e-05	0.000476	CcSEcCtD
Gliclazide—Pain—Prednisolone—rheumatoid arthritis	7.13e-05	0.000475	CcSEcCtD
Gliclazide—Hepatitis—Methotrexate—rheumatoid arthritis	7.13e-05	0.000474	CcSEcCtD
Gliclazide—Pharyngitis—Methotrexate—rheumatoid arthritis	7.08e-05	0.000471	CcSEcCtD
Gliclazide—Nausea—Leflunomide—rheumatoid arthritis	7.05e-05	0.000469	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	7.03e-05	0.000468	CcSEcCtD
Gliclazide—Fatigue—Hydrocortisone—rheumatoid arthritis	7.02e-05	0.000467	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	6.99e-05	0.000465	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	6.97e-05	0.000464	CcSEcCtD
Gliclazide—Pain—Hydrocortisone—rheumatoid arthritis	6.97e-05	0.000463	CcSEcCtD
Gliclazide—Insomnia—Triamcinolone—rheumatoid arthritis	6.94e-05	0.000462	CcSEcCtD
Gliclazide—Insomnia—Methylprednisolone—rheumatoid arthritis	6.92e-05	0.00046	CcSEcCtD
Gliclazide—Infection—Dexamethasone—rheumatoid arthritis	6.91e-05	0.00046	CcSEcCtD
Gliclazide—Infection—Betamethasone—rheumatoid arthritis	6.91e-05	0.00046	CcSEcCtD
Gliclazide—Ill-defined disorder—Prednisone—rheumatoid arthritis	6.89e-05	0.000458	CcSEcCtD
Gliclazide—Paraesthesia—Triamcinolone—rheumatoid arthritis	6.89e-05	0.000458	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisolone—rheumatoid arthritis	6.87e-05	0.000457	CcSEcCtD
Gliclazide—Paraesthesia—Methylprednisolone—rheumatoid arthritis	6.87e-05	0.000457	CcSEcCtD
Gliclazide—Visual impairment—Methotrexate—rheumatoid arthritis	6.87e-05	0.000457	CcSEcCtD
Gliclazide—Anaemia—Prednisone—rheumatoid arthritis	6.86e-05	0.000457	CcSEcCtD
Gliclazide—Dyspnoea—Triamcinolone—rheumatoid arthritis	6.84e-05	0.000455	CcSEcCtD
Gliclazide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	6.82e-05	0.000454	CcSEcCtD
Gliclazide—Nervous system disorder—Betamethasone—rheumatoid arthritis	6.82e-05	0.000454	CcSEcCtD
Gliclazide—Agitation—Prednisone—rheumatoid arthritis	6.82e-05	0.000454	CcSEcCtD
Gliclazide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	6.81e-05	0.000453	CcSEcCtD
Gliclazide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	6.81e-05	0.000453	CcSEcCtD
Gliclazide—Tachycardia—Dexamethasone—rheumatoid arthritis	6.79e-05	0.000452	CcSEcCtD
Gliclazide—Tachycardia—Betamethasone—rheumatoid arthritis	6.79e-05	0.000452	CcSEcCtD
Gliclazide—Angioedema—Prednisone—rheumatoid arthritis	6.79e-05	0.000451	CcSEcCtD
Gliclazide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	6.75e-05	0.000449	CcSEcCtD
Gliclazide—Dyspepsia—Triamcinolone—rheumatoid arthritis	6.75e-05	0.000449	CcSEcCtD
Gliclazide—Erythema multiforme—Methotrexate—rheumatoid arthritis	6.74e-05	0.000448	CcSEcCtD
Gliclazide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	6.74e-05	0.000448	CcSEcCtD
Gliclazide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	6.73e-05	0.000448	CcSEcCtD
Gliclazide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	6.73e-05	0.000448	CcSEcCtD
Gliclazide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	6.71e-05	0.000447	CcSEcCtD
Gliclazide—Malaise—Prednisone—rheumatoid arthritis	6.7e-05	0.000446	CcSEcCtD
Gliclazide—Eye disorder—Methotrexate—rheumatoid arthritis	6.66e-05	0.000443	CcSEcCtD
Gliclazide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	6.66e-05	0.000443	CcSEcCtD
Gliclazide—Tinnitus—Methotrexate—rheumatoid arthritis	6.65e-05	0.000442	CcSEcCtD
Gliclazide—Urticaria—Prednisolone—rheumatoid arthritis	6.63e-05	0.000441	CcSEcCtD
Gliclazide—Fatigue—Triamcinolone—rheumatoid arthritis	6.61e-05	0.00044	CcSEcCtD
Gliclazide—Fatigue—Methylprednisolone—rheumatoid arthritis	6.6e-05	0.000439	CcSEcCtD
Gliclazide—Asthenia—Cyclosporine—rheumatoid arthritis	6.58e-05	0.000438	CcSEcCtD
Gliclazide—Pain—Triamcinolone—rheumatoid arthritis	6.56e-05	0.000436	CcSEcCtD
Gliclazide—Loss of consciousness—Prednisone—rheumatoid arthritis	6.53e-05	0.000434	CcSEcCtD
Gliclazide—Hypotension—Dexamethasone—rheumatoid arthritis	6.5e-05	0.000433	CcSEcCtD
Gliclazide—Hypotension—Betamethasone—rheumatoid arthritis	6.5e-05	0.000433	CcSEcCtD
Gliclazide—Pruritus—Cyclosporine—rheumatoid arthritis	6.48e-05	0.000431	CcSEcCtD
Gliclazide—Urticaria—Hydrocortisone—rheumatoid arthritis	6.47e-05	0.000431	CcSEcCtD
Gliclazide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	6.44e-05	0.000428	CcSEcCtD
Gliclazide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	6.44e-05	0.000428	CcSEcCtD
Gliclazide—Convulsion—Prednisone—rheumatoid arthritis	6.43e-05	0.000428	CcSEcCtD
Gliclazide—Hypertension—Prednisone—rheumatoid arthritis	6.41e-05	0.000427	CcSEcCtD
Gliclazide—Chills—Methotrexate—rheumatoid arthritis	6.4e-05	0.000426	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	6.34e-05	0.000422	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	6.34e-05	0.000422	CcSEcCtD
Gliclazide—Myalgia—Prednisone—rheumatoid arthritis	6.32e-05	0.000421	CcSEcCtD
Gliclazide—Arthralgia—Prednisone—rheumatoid arthritis	6.32e-05	0.000421	CcSEcCtD
Gliclazide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	6.32e-05	0.00042	CcSEcCtD
Gliclazide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	6.31e-05	0.00042	CcSEcCtD
Gliclazide—Anxiety—Prednisone—rheumatoid arthritis	6.3e-05	0.000419	CcSEcCtD
Gliclazide—Insomnia—Betamethasone—rheumatoid arthritis	6.29e-05	0.000419	CcSEcCtD
Gliclazide—Insomnia—Dexamethasone—rheumatoid arthritis	6.29e-05	0.000419	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	6.28e-05	0.000418	CcSEcCtD
Gliclazide—Diarrhoea—Cyclosporine—rheumatoid arthritis	6.27e-05	0.000417	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	6.26e-05	0.000416	CcSEcCtD
Gliclazide—Paraesthesia—Dexamethasone—rheumatoid arthritis	6.25e-05	0.000416	CcSEcCtD
Gliclazide—Paraesthesia—Betamethasone—rheumatoid arthritis	6.25e-05	0.000416	CcSEcCtD
Gliclazide—Discomfort—Prednisone—rheumatoid arthritis	6.25e-05	0.000416	CcSEcCtD
Gliclazide—Mental disorder—Methotrexate—rheumatoid arthritis	6.25e-05	0.000416	CcSEcCtD
Gliclazide—Erythema—Methotrexate—rheumatoid arthritis	6.21e-05	0.000413	CcSEcCtD
Gliclazide—Malnutrition—Methotrexate—rheumatoid arthritis	6.21e-05	0.000413	CcSEcCtD
Gliclazide—Hypersensitivity—Prednisolone—rheumatoid arthritis	6.14e-05	0.000409	CcSEcCtD
Gliclazide—Dyspepsia—Dexamethasone—rheumatoid arthritis	6.13e-05	0.000408	CcSEcCtD
Gliclazide—Dyspepsia—Betamethasone—rheumatoid arthritis	6.13e-05	0.000408	CcSEcCtD
Gliclazide—Urticaria—Triamcinolone—rheumatoid arthritis	6.09e-05	0.000405	CcSEcCtD
Gliclazide—Urticaria—Methylprednisolone—rheumatoid arthritis	6.08e-05	0.000404	CcSEcCtD
Gliclazide—Body temperature increased—Triamcinolone—rheumatoid arthritis	6.06e-05	0.000403	CcSEcCtD
Gliclazide—Dizziness—Cyclosporine—rheumatoid arthritis	6.06e-05	0.000403	CcSEcCtD
Gliclazide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	6.05e-05	0.000402	CcSEcCtD
Gliclazide—Infection—Prednisone—rheumatoid arthritis	6.02e-05	0.000401	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	6.01e-05	0.0004	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	6.01e-05	0.0004	CcSEcCtD
Gliclazide—Back pain—Methotrexate—rheumatoid arthritis	6e-05	0.000399	CcSEcCtD
Gliclazide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	6e-05	0.000399	CcSEcCtD
Gliclazide—Fatigue—Betamethasone—rheumatoid arthritis	6e-05	0.000399	CcSEcCtD
Gliclazide—Fatigue—Dexamethasone—rheumatoid arthritis	6e-05	0.000399	CcSEcCtD
Gliclazide—Pain—Betamethasone—rheumatoid arthritis	5.95e-05	0.000396	CcSEcCtD
Gliclazide—Pain—Dexamethasone—rheumatoid arthritis	5.95e-05	0.000396	CcSEcCtD
Gliclazide—Nervous system disorder—Prednisone—rheumatoid arthritis	5.94e-05	0.000395	CcSEcCtD
Gliclazide—Tachycardia—Prednisone—rheumatoid arthritis	5.91e-05	0.000394	CcSEcCtD
Gliclazide—Skin disorder—Prednisone—rheumatoid arthritis	5.89e-05	0.000392	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisone—rheumatoid arthritis	5.86e-05	0.00039	CcSEcCtD
Gliclazide—Asthenia—Hydrocortisone—rheumatoid arthritis	5.84e-05	0.000389	CcSEcCtD
Gliclazide—Vomiting—Cyclosporine—rheumatoid arthritis	5.83e-05	0.000388	CcSEcCtD
Gliclazide—Rash—Cyclosporine—rheumatoid arthritis	5.78e-05	0.000384	CcSEcCtD
Gliclazide—Dermatitis—Cyclosporine—rheumatoid arthritis	5.77e-05	0.000384	CcSEcCtD
Gliclazide—Pruritus—Hydrocortisone—rheumatoid arthritis	5.76e-05	0.000383	CcSEcCtD
Gliclazide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	5.76e-05	0.000383	CcSEcCtD
Gliclazide—Headache—Cyclosporine—rheumatoid arthritis	5.74e-05	0.000382	CcSEcCtD
Gliclazide—Anaemia—Methotrexate—rheumatoid arthritis	5.74e-05	0.000382	CcSEcCtD
Gliclazide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	5.73e-05	0.000382	CcSEcCtD
Gliclazide—Feeling abnormal—Betamethasone—rheumatoid arthritis	5.73e-05	0.000382	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	5.69e-05	0.000379	CcSEcCtD
Gliclazide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	5.69e-05	0.000379	CcSEcCtD
Gliclazide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	5.65e-05	0.000376	CcSEcCtD
Gliclazide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	5.64e-05	0.000375	CcSEcCtD
Gliclazide—Malaise—Methotrexate—rheumatoid arthritis	5.6e-05	0.000372	CcSEcCtD
Gliclazide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	5.57e-05	0.000371	CcSEcCtD
Gliclazide—Leukopenia—Methotrexate—rheumatoid arthritis	5.56e-05	0.00037	CcSEcCtD
Gliclazide—Urticaria—Dexamethasone—rheumatoid arthritis	5.53e-05	0.000368	CcSEcCtD
Gliclazide—Urticaria—Betamethasone—rheumatoid arthritis	5.53e-05	0.000368	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	5.52e-05	0.000367	CcSEcCtD
Gliclazide—Dizziness—Prednisolone—rheumatoid arthritis	5.52e-05	0.000367	CcSEcCtD
Gliclazide—Asthenia—Triamcinolone—rheumatoid arthritis	5.5e-05	0.000366	CcSEcCtD
Gliclazide—Abdominal pain—Betamethasone—rheumatoid arthritis	5.5e-05	0.000366	CcSEcCtD
Gliclazide—Abdominal pain—Dexamethasone—rheumatoid arthritis	5.5e-05	0.000366	CcSEcCtD
Gliclazide—Body temperature increased—Betamethasone—rheumatoid arthritis	5.5e-05	0.000366	CcSEcCtD
Gliclazide—Body temperature increased—Dexamethasone—rheumatoid arthritis	5.5e-05	0.000366	CcSEcCtD
Gliclazide—Asthenia—Methylprednisolone—rheumatoid arthritis	5.49e-05	0.000365	CcSEcCtD
Gliclazide—Insomnia—Prednisone—rheumatoid arthritis	5.48e-05	0.000365	CcSEcCtD
Gliclazide—Nausea—Cyclosporine—rheumatoid arthritis	5.44e-05	0.000362	CcSEcCtD
Gliclazide—Paraesthesia—Prednisone—rheumatoid arthritis	5.44e-05	0.000362	CcSEcCtD
Gliclazide—Pruritus—Triamcinolone—rheumatoid arthritis	5.43e-05	0.000361	CcSEcCtD
Gliclazide—Cough—Methotrexate—rheumatoid arthritis	5.42e-05	0.00036	CcSEcCtD
Gliclazide—Pruritus—Methylprednisolone—rheumatoid arthritis	5.41e-05	0.00036	CcSEcCtD
Gliclazide—Dizziness—Hydrocortisone—rheumatoid arthritis	5.39e-05	0.000358	CcSEcCtD
Gliclazide—Convulsion—Methotrexate—rheumatoid arthritis	5.38e-05	0.000358	CcSEcCtD
Gliclazide—Dyspepsia—Prednisone—rheumatoid arthritis	5.33e-05	0.000355	CcSEcCtD
Gliclazide—Myalgia—Methotrexate—rheumatoid arthritis	5.28e-05	0.000352	CcSEcCtD
Gliclazide—Chest pain—Methotrexate—rheumatoid arthritis	5.28e-05	0.000352	CcSEcCtD
Gliclazide—Arthralgia—Methotrexate—rheumatoid arthritis	5.28e-05	0.000352	CcSEcCtD
Gliclazide—Rash—Prednisolone—rheumatoid arthritis	5.26e-05	0.00035	CcSEcCtD
Gliclazide—Dermatitis—Prednisolone—rheumatoid arthritis	5.25e-05	0.00035	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	5.25e-05	0.000349	CcSEcCtD
Gliclazide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.000348	CcSEcCtD
Gliclazide—Fatigue—Prednisone—rheumatoid arthritis	5.23e-05	0.000348	CcSEcCtD
Gliclazide—Headache—Prednisolone—rheumatoid arthritis	5.22e-05	0.000348	CcSEcCtD
Gliclazide—Discomfort—Methotrexate—rheumatoid arthritis	5.22e-05	0.000347	CcSEcCtD
Gliclazide—Constipation—Prednisone—rheumatoid arthritis	5.18e-05	0.000345	CcSEcCtD
Gliclazide—Vomiting—Hydrocortisone—rheumatoid arthritis	5.18e-05	0.000345	CcSEcCtD
Gliclazide—Rash—Hydrocortisone—rheumatoid arthritis	5.14e-05	0.000342	CcSEcCtD
Gliclazide—Dermatitis—Hydrocortisone—rheumatoid arthritis	5.13e-05	0.000341	CcSEcCtD
Gliclazide—Confusional state—Methotrexate—rheumatoid arthritis	5.11e-05	0.00034	CcSEcCtD
Gliclazide—Headache—Hydrocortisone—rheumatoid arthritis	5.1e-05	0.000339	CcSEcCtD
Gliclazide—Dizziness—Triamcinolone—rheumatoid arthritis	5.07e-05	0.000337	CcSEcCtD
Gliclazide—Dizziness—Methylprednisolone—rheumatoid arthritis	5.06e-05	0.000337	CcSEcCtD
Gliclazide—Infection—Methotrexate—rheumatoid arthritis	5.03e-05	0.000335	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisone—rheumatoid arthritis	4.99e-05	0.000332	CcSEcCtD
Gliclazide—Asthenia—Betamethasone—rheumatoid arthritis	4.99e-05	0.000332	CcSEcCtD
Gliclazide—Asthenia—Dexamethasone—rheumatoid arthritis	4.99e-05	0.000332	CcSEcCtD
Gliclazide—Nervous system disorder—Methotrexate—rheumatoid arthritis	4.97e-05	0.00033	CcSEcCtD
Gliclazide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	4.96e-05	0.00033	CcSEcCtD
Gliclazide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4.96e-05	0.00033	CcSEcCtD
Gliclazide—Nausea—Prednisolone—rheumatoid arthritis	4.95e-05	0.00033	CcSEcCtD
Gliclazide—Pruritus—Dexamethasone—rheumatoid arthritis	4.92e-05	0.000328	CcSEcCtD
Gliclazide—Pruritus—Betamethasone—rheumatoid arthritis	4.92e-05	0.000328	CcSEcCtD
Gliclazide—Skin disorder—Methotrexate—rheumatoid arthritis	4.92e-05	0.000327	CcSEcCtD
Gliclazide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	4.9e-05	0.000326	CcSEcCtD
Gliclazide—Vomiting—Triamcinolone—rheumatoid arthritis	4.88e-05	0.000324	CcSEcCtD
Gliclazide—Vomiting—Methylprednisolone—rheumatoid arthritis	4.87e-05	0.000324	CcSEcCtD
Gliclazide—Nausea—Hydrocortisone—rheumatoid arthritis	4.84e-05	0.000322	CcSEcCtD
Gliclazide—Rash—Triamcinolone—rheumatoid arthritis	4.84e-05	0.000322	CcSEcCtD
Gliclazide—Dermatitis—Triamcinolone—rheumatoid arthritis	4.83e-05	0.000321	CcSEcCtD
Gliclazide—Rash—Methylprednisolone—rheumatoid arthritis	4.83e-05	0.000321	CcSEcCtD
Gliclazide—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.82e-05	0.000321	CcSEcCtD
Gliclazide—Urticaria—Prednisone—rheumatoid arthritis	4.81e-05	0.00032	CcSEcCtD
Gliclazide—Headache—Triamcinolone—rheumatoid arthritis	4.8e-05	0.00032	CcSEcCtD
Gliclazide—Headache—Methylprednisolone—rheumatoid arthritis	4.79e-05	0.000319	CcSEcCtD
Gliclazide—Body temperature increased—Prednisone—rheumatoid arthritis	4.79e-05	0.000319	CcSEcCtD
Gliclazide—Abdominal pain—Prednisone—rheumatoid arthritis	4.79e-05	0.000319	CcSEcCtD
Gliclazide—Diarrhoea—Dexamethasone—rheumatoid arthritis	4.76e-05	0.000317	CcSEcCtD
Gliclazide—Diarrhoea—Betamethasone—rheumatoid arthritis	4.76e-05	0.000317	CcSEcCtD
Gliclazide—Hypotension—Methotrexate—rheumatoid arthritis	4.73e-05	0.000315	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—IL6R—rheumatoid arthritis	4.67e-05	0.000684	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	4.63e-05	0.000678	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	4.61e-05	0.000307	CcSEcCtD
Gliclazide—Dizziness—Betamethasone—rheumatoid arthritis	4.6e-05	0.000306	CcSEcCtD
Gliclazide—Dizziness—Dexamethasone—rheumatoid arthritis	4.6e-05	0.000306	CcSEcCtD
Gliclazide—ABCC8—Metabolism—B3GNT2—rheumatoid arthritis	4.59e-05	0.000671	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ACP5—rheumatoid arthritis	4.59e-05	0.000671	CbGpPWpGaD
Gliclazide—Insomnia—Methotrexate—rheumatoid arthritis	4.58e-05	0.000305	CcSEcCtD
Gliclazide—Nausea—Triamcinolone—rheumatoid arthritis	4.56e-05	0.000303	CcSEcCtD
Gliclazide—Paraesthesia—Methotrexate—rheumatoid arthritis	4.55e-05	0.000303	CcSEcCtD
Gliclazide—Nausea—Methylprednisolone—rheumatoid arthritis	4.55e-05	0.000302	CcSEcCtD
Gliclazide—Dyspnoea—Methotrexate—rheumatoid arthritis	4.52e-05	0.0003	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—PDE2A—rheumatoid arthritis	4.51e-05	0.00066	CbGpPWpGaD
Gliclazide—Somnolence—Methotrexate—rheumatoid arthritis	4.5e-05	0.0003	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—IL1B—rheumatoid arthritis	4.48e-05	0.000656	CbGpPWpGaD
Gliclazide—Hypersensitivity—Prednisone—rheumatoid arthritis	4.47e-05	0.000297	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—IL2—rheumatoid arthritis	4.46e-05	0.000654	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—MMP2—rheumatoid arthritis	4.46e-05	0.000653	CbGpPWpGaD
Gliclazide—Dyspepsia—Methotrexate—rheumatoid arthritis	4.46e-05	0.000297	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.45e-05	0.000652	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ACP5—rheumatoid arthritis	4.45e-05	0.000651	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—B3GNT2—rheumatoid arthritis	4.45e-05	0.000651	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TIMP1—rheumatoid arthritis	4.44e-05	0.000651	CbGpPWpGaD
Gliclazide—Vomiting—Dexamethasone—rheumatoid arthritis	4.42e-05	0.000294	CcSEcCtD
Gliclazide—Vomiting—Betamethasone—rheumatoid arthritis	4.42e-05	0.000294	CcSEcCtD
Gliclazide—Rash—Dexamethasone—rheumatoid arthritis	4.39e-05	0.000292	CcSEcCtD
Gliclazide—Rash—Betamethasone—rheumatoid arthritis	4.39e-05	0.000292	CcSEcCtD
Gliclazide—Dermatitis—Betamethasone—rheumatoid arthritis	4.38e-05	0.000292	CcSEcCtD
Gliclazide—Dermatitis—Dexamethasone—rheumatoid arthritis	4.38e-05	0.000292	CcSEcCtD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.38e-05	0.000641	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.38e-05	0.000641	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	4.37e-05	0.000291	CcSEcCtD
Gliclazide—Fatigue—Methotrexate—rheumatoid arthritis	4.37e-05	0.000291	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CXCL8—rheumatoid arthritis	4.37e-05	0.000639	CbGpPWpGaD
Gliclazide—Headache—Betamethasone—rheumatoid arthritis	4.36e-05	0.00029	CcSEcCtD
Gliclazide—Headache—Dexamethasone—rheumatoid arthritis	4.36e-05	0.00029	CcSEcCtD
Gliclazide—Asthenia—Prednisone—rheumatoid arthritis	4.35e-05	0.000289	CcSEcCtD
Gliclazide—Pain—Methotrexate—rheumatoid arthritis	4.33e-05	0.000288	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	4.32e-05	0.000633	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PLB1—rheumatoid arthritis	4.3e-05	0.000629	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLEK—rheumatoid arthritis	4.29e-05	0.000628	CbGpPWpGaD
Gliclazide—Pruritus—Prednisone—rheumatoid arthritis	4.29e-05	0.000285	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—TYK2—rheumatoid arthritis	4.26e-05	0.000623	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2RA—rheumatoid arthritis	4.23e-05	0.000619	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	4.22e-05	0.000617	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	4.19e-05	0.000613	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—NFKB1—rheumatoid arthritis	4.18e-05	0.000612	CbGpPWpGaD
Gliclazide—Feeling abnormal—Methotrexate—rheumatoid arthritis	4.17e-05	0.000278	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	4.17e-05	0.00061	CbGpPWpGaD
Gliclazide—Diarrhoea—Prednisone—rheumatoid arthritis	4.15e-05	0.000276	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	4.14e-05	0.000276	CcSEcCtD
Gliclazide—Nausea—Dexamethasone—rheumatoid arthritis	4.13e-05	0.000275	CcSEcCtD
Gliclazide—Nausea—Betamethasone—rheumatoid arthritis	4.13e-05	0.000275	CcSEcCtD
Gliclazide—ABCC8—Metabolism—BGN—rheumatoid arthritis	4.13e-05	0.000605	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.07e-05	0.000596	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.06e-05	0.000594	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—MMP1—rheumatoid arthritis	4.04e-05	0.000591	CbGpPWpGaD
Gliclazide—Urticaria—Methotrexate—rheumatoid arthritis	4.02e-05	0.000268	CcSEcCtD
Gliclazide—Dizziness—Prednisone—rheumatoid arthritis	4.01e-05	0.000267	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—BGN—rheumatoid arthritis	4e-05	0.000586	CbGpPWpGaD
Gliclazide—Abdominal pain—Methotrexate—rheumatoid arthritis	4e-05	0.000266	CcSEcCtD
Gliclazide—Body temperature increased—Methotrexate—rheumatoid arthritis	4e-05	0.000266	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—RASGRP1—rheumatoid arthritis	4e-05	0.000585	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—rheumatoid arthritis	4e-05	0.000585	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	3.99e-05	0.000584	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SYK—rheumatoid arthritis	3.99e-05	0.000584	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—LEP—rheumatoid arthritis	3.98e-05	0.000583	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RBPJ—rheumatoid arthritis	3.97e-05	0.000581	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.94e-05	0.000576	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	3.93e-05	0.000576	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	3.93e-05	0.000576	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PRKCQ—rheumatoid arthritis	3.91e-05	0.000573	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—NFKB1—rheumatoid arthritis	3.91e-05	0.000572	CbGpPWpGaD
Gliclazide—Vomiting—Prednisone—rheumatoid arthritis	3.85e-05	0.000256	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—MAPK8—rheumatoid arthritis	3.84e-05	0.000562	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—rheumatoid arthritis	3.83e-05	0.00056	CbGpPWpGaD
Gliclazide—Rash—Prednisone—rheumatoid arthritis	3.82e-05	0.000254	CcSEcCtD
Gliclazide—Dermatitis—Prednisone—rheumatoid arthritis	3.82e-05	0.000254	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ALOX5—rheumatoid arthritis	3.8e-05	0.000556	CbGpPWpGaD
Gliclazide—Headache—Prednisone—rheumatoid arthritis	3.8e-05	0.000253	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	3.75e-05	0.000549	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6ST—rheumatoid arthritis	3.74e-05	0.000547	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	3.74e-05	0.000547	CbGpPWpGaD
Gliclazide—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.73e-05	0.000248	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—ALOX5—rheumatoid arthritis	3.69e-05	0.00054	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—FN1—rheumatoid arthritis	3.68e-05	0.000539	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.66e-05	0.000535	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS2—rheumatoid arthritis	3.64e-05	0.000533	CbGpPWpGaD
Gliclazide—Asthenia—Methotrexate—rheumatoid arthritis	3.63e-05	0.000242	CcSEcCtD
Gliclazide—Nausea—Prednisone—rheumatoid arthritis	3.6e-05	0.00024	CcSEcCtD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	3.59e-05	0.000525	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	3.59e-05	0.000525	CbGpPWpGaD
Gliclazide—Pruritus—Methotrexate—rheumatoid arthritis	3.58e-05	0.000238	CcSEcCtD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.57e-05	0.000523	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	3.56e-05	0.000521	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL13—rheumatoid arthritis	3.5e-05	0.000513	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.47e-05	0.000508	CbGpPWpGaD
Gliclazide—Diarrhoea—Methotrexate—rheumatoid arthritis	3.47e-05	0.000231	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	3.4e-05	0.000497	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—MMP9—rheumatoid arthritis	3.35e-05	0.000491	CbGpPWpGaD
Gliclazide—Dizziness—Methotrexate—rheumatoid arthritis	3.35e-05	0.000223	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—IL6R—rheumatoid arthritis	3.34e-05	0.000488	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.33e-05	0.000488	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PTK2—rheumatoid arthritis	3.33e-05	0.000487	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	3.32e-05	0.000486	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FADS2—rheumatoid arthritis	3.31e-05	0.000485	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—VEGFA—rheumatoid arthritis	3.25e-05	0.000476	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—rheumatoid arthritis	3.25e-05	0.000476	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—rheumatoid arthritis	3.23e-05	0.000472	CbGpPWpGaD
Gliclazide—Vomiting—Methotrexate—rheumatoid arthritis	3.22e-05	0.000214	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CSF2—rheumatoid arthritis	3.21e-05	0.00047	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.21e-05	0.000469	CbGpPWpGaD
Gliclazide—Rash—Methotrexate—rheumatoid arthritis	3.19e-05	0.000212	CcSEcCtD
Gliclazide—Dermatitis—Methotrexate—rheumatoid arthritis	3.19e-05	0.000212	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—MMP2—rheumatoid arthritis	3.18e-05	0.000466	CbGpPWpGaD
Gliclazide—Headache—Methotrexate—rheumatoid arthritis	3.17e-05	0.000211	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—TLE3—rheumatoid arthritis	3.15e-05	0.000462	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRAK1—rheumatoid arthritis	3.15e-05	0.000462	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2RB—rheumatoid arthritis	3.13e-05	0.000458	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CX3CR1—rheumatoid arthritis	3.12e-05	0.000457	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—rheumatoid arthritis	3.1e-05	0.000454	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ENO1—rheumatoid arthritis	3.1e-05	0.000454	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ALB—rheumatoid arthritis	3.06e-05	0.000448	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TYK2—rheumatoid arthritis	3.04e-05	0.000445	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SELE—rheumatoid arthritis	3.02e-05	0.000442	CbGpPWpGaD
Gliclazide—Nausea—Methotrexate—rheumatoid arthritis	3.01e-05	0.0002	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—IL2RB—rheumatoid arthritis	3.01e-05	0.00044	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ENO1—rheumatoid arthritis	3e-05	0.00044	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TGFB1—rheumatoid arthritis	2.99e-05	0.000437	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FADS2—rheumatoid arthritis	2.97e-05	0.000435	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS3—rheumatoid arthritis	2.93e-05	0.000428	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	2.92e-05	0.000428	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C5—rheumatoid arthritis	2.9e-05	0.000425	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.9e-05	0.000424	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	2.9e-05	0.000424	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—rheumatoid arthritis	2.87e-05	0.00042	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFATC1—rheumatoid arthritis	2.86e-05	0.000418	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—rheumatoid arthritis	2.84e-05	0.000416	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—ITGAM—rheumatoid arthritis	2.84e-05	0.000416	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.75e-05	0.000403	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR6—rheumatoid arthritis	2.73e-05	0.0004	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	2.71e-05	0.000397	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SH2B3—rheumatoid arthritis	2.69e-05	0.000394	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—rheumatoid arthritis	2.68e-05	0.000392	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NCF2—rheumatoid arthritis	2.66e-05	0.000389	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—rheumatoid arthritis	2.62e-05	0.000384	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	2.59e-05	0.00038	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SH2B3—rheumatoid arthritis	2.59e-05	0.000379	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TRAF6—rheumatoid arthritis	2.59e-05	0.000379	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.58e-05	0.000378	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GZMB—rheumatoid arthritis	2.57e-05	0.000377	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	2.52e-05	0.000369	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—rheumatoid arthritis	2.52e-05	0.000369	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL2—rheumatoid arthritis	2.5e-05	0.000366	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL3—rheumatoid arthritis	2.5e-05	0.000366	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—rheumatoid arthritis	2.48e-05	0.000363	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.47e-05	0.000362	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—rheumatoid arthritis	2.45e-05	0.000359	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SAA1—rheumatoid arthritis	2.44e-05	0.000357	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GATA3—rheumatoid arthritis	2.42e-05	0.000354	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP9—rheumatoid arthritis	2.39e-05	0.00035	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NCF1—rheumatoid arthritis	2.39e-05	0.00035	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NFKB1—rheumatoid arthritis	2.37e-05	0.000347	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD28—rheumatoid arthritis	2.3e-05	0.000337	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	2.3e-05	0.000336	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TIMP1—rheumatoid arthritis	2.29e-05	0.000335	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.25e-05	0.00033	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAT—rheumatoid arthritis	2.23e-05	0.000326	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLD4—rheumatoid arthritis	2.21e-05	0.000323	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.16e-05	0.000317	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAT—rheumatoid arthritis	2.16e-05	0.000317	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ACAN—rheumatoid arthritis	2.13e-05	0.000312	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL12—rheumatoid arthritis	2.12e-05	0.000311	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.12e-05	0.000311	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.1e-05	0.000307	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—rheumatoid arthritis	2.08e-05	0.000305	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—rheumatoid arthritis	2.08e-05	0.000305	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RASGRP1—rheumatoid arthritis	2.06e-05	0.000302	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SYK—rheumatoid arthritis	2.05e-05	0.000301	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PRKCQ—rheumatoid arthritis	2.02e-05	0.000295	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC25A12—rheumatoid arthritis	2.01e-05	0.000294	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLD4—rheumatoid arthritis	1.98e-05	0.00029	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.98e-05	0.00029	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SYK—rheumatoid arthritis	1.97e-05	0.000289	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—rheumatoid arthritis	1.97e-05	0.000289	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GC—rheumatoid arthritis	1.95e-05	0.000286	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGES—rheumatoid arthritis	1.95e-05	0.000286	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.94e-05	0.000284	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—rheumatoid arthritis	1.93e-05	0.000283	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	1.92e-05	0.00028	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT1—rheumatoid arthritis	1.9e-05	0.000279	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL10—rheumatoid arthritis	1.88e-05	0.000275	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—rheumatoid arthritis	1.86e-05	0.000272	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—rheumatoid arthritis	1.84e-05	0.00027	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLB1—rheumatoid arthritis	1.81e-05	0.000266	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	1.81e-05	0.000265	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—rheumatoid arthritis	1.8e-05	0.000264	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	1.8e-05	0.000264	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	1.75e-05	0.000256	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GC—rheumatoid arthritis	1.75e-05	0.000256	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	1.75e-05	0.000256	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PTK2—rheumatoid arthritis	1.71e-05	0.000251	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP3—rheumatoid arthritis	1.71e-05	0.000251	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	1.7e-05	0.000249	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CSF2—rheumatoid arthritis	1.66e-05	0.000242	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTK2—rheumatoid arthritis	1.65e-05	0.000241	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	1.64e-05	0.00024	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	1.63e-05	0.000238	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL5—rheumatoid arthritis	1.62e-05	0.000236	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	1.6e-05	0.000234	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GC—rheumatoid arthritis	1.6e-05	0.000234	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—rheumatoid arthritis	1.59e-05	0.000233	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CSF2—rheumatoid arthritis	1.59e-05	0.000233	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MED1—rheumatoid arthritis	1.59e-05	0.000233	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SPP1—rheumatoid arthritis	1.5e-05	0.000219	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2RA—rheumatoid arthritis	1.49e-05	0.000219	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—rheumatoid arthritis	1.49e-05	0.000218	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—rheumatoid arthritis	1.49e-05	0.000218	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	1.48e-05	0.000217	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ACP5—rheumatoid arthritis	1.48e-05	0.000217	CbGpPWpGaD
Gliclazide—ALB—Metabolism—B3GNT2—rheumatoid arthritis	1.48e-05	0.000217	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—rheumatoid arthritis	1.46e-05	0.000213	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—rheumatoid arthritis	1.44e-05	0.000211	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	1.44e-05	0.000211	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2RA—rheumatoid arthritis	1.43e-05	0.00021	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MED1—rheumatoid arthritis	1.43e-05	0.000209	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MMP1—rheumatoid arthritis	1.42e-05	0.000208	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C3—rheumatoid arthritis	1.42e-05	0.000208	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—rheumatoid arthritis	1.36e-05	0.000199	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BGN—rheumatoid arthritis	1.33e-05	0.000195	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	1.33e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	1.33e-05	0.000194	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	1.32e-05	0.000194	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—rheumatoid arthritis	1.32e-05	0.000194	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—rheumatoid arthritis	1.32e-05	0.000193	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.3e-05	0.000191	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FN1—rheumatoid arthritis	1.3e-05	0.00019	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—rheumatoid arthritis	1.3e-05	0.00019	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—rheumatoid arthritis	1.28e-05	0.000188	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—rheumatoid arthritis	1.26e-05	0.000184	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FN1—rheumatoid arthritis	1.25e-05	0.000183	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6ST—rheumatoid arthritis	1.24e-05	0.000182	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALOX5—rheumatoid arthritis	1.23e-05	0.000179	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.21e-05	0.000177	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.21e-05	0.000177	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD80—rheumatoid arthritis	1.2e-05	0.000175	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BGN—rheumatoid arthritis	1.2e-05	0.000175	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—rheumatoid arthritis	1.19e-05	0.000174	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—rheumatoid arthritis	1.15e-05	0.000169	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—rheumatoid arthritis	1.14e-05	0.000166	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—rheumatoid arthritis	1.11e-05	0.000163	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6R—rheumatoid arthritis	1.11e-05	0.000162	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	1.1e-05	0.000161	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BGN—rheumatoid arthritis	1.09e-05	0.00016	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.08e-05	0.000158	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—rheumatoid arthritis	1.03e-05	0.000151	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TYK2—rheumatoid arthritis	1.01e-05	0.000148	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1e-05	0.000147	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ENO1—rheumatoid arthritis	9.99e-06	0.000146	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—rheumatoid arthritis	9.92e-06	0.000145	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.67e-06	0.000142	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	8.97e-06	0.000131	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.82e-06	0.000129	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.82e-06	0.000129	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—rheumatoid arthritis	8.8e-06	0.000129	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—rheumatoid arthritis	8.75e-06	0.000128	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	8.6e-06	0.000126	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—rheumatoid arthritis	8.41e-06	0.000123	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	8.18e-06	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.04e-06	0.000118	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—rheumatoid arthritis	7.96e-06	0.000116	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFKB1—rheumatoid arthritis	7.87e-06	0.000115	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAPK8—rheumatoid arthritis	7.74e-06	0.000113	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.72e-06	0.000113	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—rheumatoid arthritis	7.44e-06	0.000109	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—rheumatoid arthritis	7.19e-06	0.000105	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.04e-06	0.000103	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—rheumatoid arthritis	6.83e-06	9.99e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—rheumatoid arthritis	6.56e-06	9.6e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—rheumatoid arthritis	6.45e-06	9.45e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—rheumatoid arthritis	6e-06	8.79e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—rheumatoid arthritis	5.89e-06	8.62e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—rheumatoid arthritis	5.62e-06	8.23e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—rheumatoid arthritis	5.4e-06	7.9e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	5.39e-06	7.89e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—rheumatoid arthritis	4.94e-06	7.23e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	4.91e-06	7.19e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—rheumatoid arthritis	4.8e-06	7.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—rheumatoid arthritis	4.31e-06	6.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—rheumatoid arthritis	4.19e-06	6.13e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—rheumatoid arthritis	3.93e-06	5.75e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—rheumatoid arthritis	3.93e-06	5.75e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—rheumatoid arthritis	3.83e-06	5.6e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	3.76e-06	5.5e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—rheumatoid arthritis	3.58e-06	5.24e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	3.44e-06	5.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	3.43e-06	5.02e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	3.13e-06	4.59e-05	CbGpPWpGaD
